Literature DB >> 25293394

Super-infection with Staphylococcus aureus inhibits influenza virus-induced type I IFN signalling through impaired STAT1-STAT2 dimerization.

Kathrin Warnking1, Carolin Klemm, Bettina Löffler, Silke Niemann, Andre van Krüchten, Georg Peters, Stephan Ludwig, Christina Ehrhardt.   

Abstract

Bacterial super-infections are a major complication in influenza virus-infected patients. In response to infection with influenza viruses and bacteria, a complex interplay of cellular signalling mechanisms is initiated, regulating the anti-pathogen response but also pathogen-supportive functions. Here, we show that influenza viruses replicate to a higher efficiency in cells co-infected with Staphylococcus aureus (S. aureus). While cells initially respond with increased induction of interferon beta upon super-infection, subsequent interferon signalling and interferon-stimulated gene expression are rather impaired due to a block of STAT1-STAT2 dimerization. Thus, S. aureus interrupts the first line of defence against influenza viruses, resulting in a boost of viral replication, which may lead to enhanced viral pathogenicity.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25293394     DOI: 10.1111/cmi.12375

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  19 in total

1.  RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness.

Authors:  Tanya Novak; Mark W Hall; Douglas R McDonald; Margaret M Newhams; Anushay J Mistry; Angela Panoskaltsis-Mortari; Peter M Mourani; Laura L Loftis; Scott L Weiss; Keiko M Tarquinio; Barry Markovitz; Mary E Hartman; Adam Schwarz; Wolfgang G Junger; Adrienne G Randolph
Journal:  J Allergy Clin Immunol       Date:  2020-02-06       Impact factor: 10.793

2.  Bioinformatics analyses of significant genes, related pathways, and candidate diagnostic biomarkers and molecular targets in SARS-CoV-2/COVID-19.

Authors:  Basavaraj Vastrad; Chanabasayya Vastrad; Anandkumar Tengli
Journal:  Gene Rep       Date:  2020-11-04

3.  Validated Models of Immune Response to Virus Infection.

Authors:  Amber M Smith
Journal:  Curr Opin Syst Biol       Date:  2018-10-31

Review 4.  Exposing the Two Contrasting Faces of STAT2 in Inflammation.

Authors:  Philip Duodu; Geohaira Sosa; Jorge Canar; Olivia Chhugani; Ana M Gamero
Journal:  J Interferon Cytokine Res       Date:  2022-07-25       Impact factor: 3.657

5.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

6.  A Critical, Nonlinear Threshold Dictates Bacterial Invasion and Initial Kinetics During Influenza.

Authors:  Amber M Smith; Amanda P Smith
Journal:  Sci Rep       Date:  2016-12-15       Impact factor: 4.379

7.  Mitogen-activated protein kinases (MAPKs) regulate IL-6 over-production during concomitant influenza virus and Staphylococcus aureus infection.

Authors:  Carolin Klemm; Christin Bruchhagen; Andre van Krüchten; Silke Niemann; Bettina Löffler; Georg Peters; Stephan Ludwig; Christina Ehrhardt
Journal:  Sci Rep       Date:  2017-02-14       Impact factor: 4.379

Review 8.  Altered Signal Transduction in the Immune Response to Influenza Virus and S. pneumoniae or S. aureus Co-Infections.

Authors:  Janine J Wilden; Jasmin C Jacob; Christina Ehrhardt; Stephan Ludwig; Yvonne Boergeling
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 5.923

9.  Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive Disease.

Authors:  Ryan M Reddinger; Nicole R Luke-Marshall; Anders P Hakansson; Anthony A Campagnari
Journal:  mBio       Date:  2016-08-09       Impact factor: 7.867

10.  Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza.

Authors:  Amber M Smith
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-09-27       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.